Search clinical trials for: Pegvaliase

Total 10 results

BioMarin Pharmaceutical

Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) (PALace)

Phenylketonuria (PKU)

United States, Germany, Italy
BioMarin Pharmaceutical

Recruiting

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

Phenylketonuria (PKU)

United States
BioMarin Pharmaceutical
Syneos Health

Recruiting

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding (PALomino)

Phenylketonuria, Maternal

Germany, United States, Italy
BioMarin Pharmaceutical

Completed

Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU

Phenylketonuria (PKU)

United States
Boston Children's Hospital
BioMarin Pharmaceutical

Completed

Nutrition Status of Adults Treated With Pegvaliase

Phenylketonurias

United States
Emory University
BioMarin Pharmaceutical

Recruiting

Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Phenylketonuria

United States
University of Missouri-Columbia
BioMarin Pharmaceutical

Enrolling by invitation

Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU

Phenylketonurias

United States
BioMarin Pharmaceutical

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria (PEGASUS)

Phenylketonuria (PKU)

United States, Germany
BioMarin Pharmaceutical

Completed

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 (Prism301)

Phenylketonuria

United States

3

Subscribe